Reflections on science in the time of COVID refracted through literature. By a true inspiration, my Dad. Hell, heaven, a whale and me asbmb.org/asbmb-today/op…

So cool to see Dr. Gomez leading the charge. Just adds to the legend.

New Penn Medicine - Abramson Cancer Center study identifies systemic inflammation in the blood as a potential resistance mechanism to #CD40-based immunotherapies in advanced pancreatic cancer patients + suggests biomarkers for future studies ft. Max Wattenberg & Beatty Lab bit.ly/374u0Ei

Now available !!! 🌔 So many people go into making words into poems and poems into books and I’m so so grateful to every hand, ear, eye that’s touched this.

Today's Featured Poet: Madeleine Wattenberg is the author of I/O (Univ. of Arkansas Press). Her work appears in journals such as Salamander, The Rumpus , Puerto del Sol, Sixth Finch, & Guernica Magazine. She is a PhD candidate at University of Cincinnati and serves as Associate Editor for the Cincinnati Review.

Physician-scientists/clinical fellows: apply now for the AACR Molecular Biology in Clinical Oncology Workshop! For over 25 years this workshop has trained this critical cohort of the cancer workforce! Apps due May 11. aacr.org/meeting/mbco-2… #doubledocs #physicianscientists

This year of all years, May the Fourth Be With You, Quakers! #maythe4th #starwarsday

Can’t recommend this workshop enough. Taking place July19-23, 2021. Application deadline this Tuesday, May 11, details can be found at the following link: aacr.org/meeting/mbco-2… Amy A. Baran Ross Levine

Thank you Damon Runyon Cancer Research Foundation for your support of physician scientists! This is exceptionally cool 🎉 Also many thanks to Gregory Beatty (Beatty Lab)and Bob Vonderheide for their mentorship. Onward! Penn Medicine

Thanks Madeleine Wattenberg and The Incredible Exploding Man !!

👀👀👀Oh hayy look we wrote a thing!! Serum Amyloid A Proteins and Their Impact on Metastasis and Immune Biology in Cancer mdpi.com/1164910 MDPI

I wrote a little poem a couple years ago about climate change and all the billionaires going to space -- seems like the time to share it again (w thanks @hobartpulp for publishing it) hobartpulp.com/web_features/i… (@hobartpulp)

IRAK4 signaling drives resistance to checkpoint immunotherapy in pancreatic ductal adenocarcinoma gastrojournal.org/article/S0016-…

Congrats! Amazing work.

Combining two treatments that activate myeloid cells may prove successful against tumors where conventional T cell-based immunotherapies have failed, indicates new research in mouse models of pancreatic cancer. Max Wattenberg Beatty Lab Penn Medicine 📄: scim.ag/4RU